Adverse events13

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 13 of 13

Type	Event	Organ system	Group	Affected	At risk	Events
other	Urinary Tract Infection	Renal and urinary disorders	Alemtuzumab	1	7	1
other	Hives	Skin and subcutaneous tissue disorders	Alemtuzumab	1	7	1
other	Mucositis	Gastrointestinal disorders	Alemtuzumab	1	7	1
other	Nausea and Vomiting	Gastrointestinal disorders	Alemtuzumab	2	7	2
other	Hypotension	Cardiac disorders	Alemtuzumab	1	7	1
other	Elevated ALT	Metabolism and nutrition disorders	Alemtuzumab	1	7	1
other	Elevated AST	Metabolism and nutrition disorders	Alemtuzumab	1	7	1
other	Chills	General disorders	Alemtuzumab	1	7	1
other	Headache	Nervous system disorders	Alemtuzumab	1	7	1
serious	Bacteremia	Infections and infestations	Alemtuzumab	1	7	1
serious	Bladder infection	Infections and infestations	Alemtuzumab	1	7	1
serious	Febrile Neutropenia	Infections and infestations	Alemtuzumab	1	7	1
serious	Septic Shock	Infections and infestations	Alemtuzumab	1	7	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01191749/events